Evolving Options in First Line Treatment of ALK PositiveNon Small Cell Lung Cancer NSCLC [720p]
Presented by Dr. Luis E. Raez, MD, FACP, FCCP Chief of Hematology/Oncology and Medical Director of Memorial Cancer Institute (Miami, FL) Clinical Associate Professor of Medicine, Herbert Wertheim Coll...
Author: cancergrace
Added: 04/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Neoadjuvant Immunotherapy Data Suggest More Lung Cancer Cures
Among the new data on immunotherapy for lung cancer presented at the recent AACR meeting, the potential role of immune checkpoint inhibitors in the neoadjuvant setting may be the most promising. (Source: Medscape Oncology)
Source: Medscape Oncology - April 26, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Checkpoint Inhibitors Have a Role for 'Virtually Every Patient'
After an ' extraordinary week ' of advances in lung cancer, Dr Mark Kris explains why checkpoint inhibitors now play a major role in lung cancer therapy. (Source: Medscape Oncology)
Source: Medscape Oncology - April 25, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line Treatment [720p]
A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line Treatment
Author: cancergrace
Added: 04/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Are MET Mutations Now a Mutation We Should Look for in Lung Cancer_ [720p]
Sequencing Treatments for ALK+ Lung Cancer in a Crowded Field Is there a place for Lorlatinib?
Author: cancergrace
Added: 04/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Are MET Mutations Now a Mutation We Should Look for in Lung Cancer_ [720p]
Are MET Mutations Now a Mutation We Should Look for in Lung Cancer?
Author: cancergrace
Added: 04/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 23, 2018 Category: Cancer & Oncology Source Type: podcasts
What is the role for Immunotherapy in Relapsed Small Cell Lung Cancer after ASCO 2017_ [720p]
What is the role for Immunotherapy in Relapsed Small Cell Lung Cancer after ASCO 2017?
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Reirradiation of Tumor in a Previously Radiated Field [720p]
Radiation oncologist Dr. Chris Loiselle reviews the possibility of re-treating with radiation for lung cancer, typically using stereotactic technique, in a previously irradiated field.
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Prophylactic Cranial Irradiation for Extensive Stage Small Cell Lung Cancer [720p]
Why radiate a perfectly good brain? Dr. Vivek Mehta, radiation oncologist, discusses the possible role for prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (SCLC) to d...
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
First Line Treatment of EGFR Mutation-Positive NSCLC [720p]
MSKCC medical oncologist Dr. Greg Riely reviews the optimal first line treatment of patients with an EGFR mutation-positive advanced lung cancer.
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC_ [720p]
Drs. Leora Horn, Ben Solomon, & Jack West debate whether results from a European trial of chest radiation after chemotherapy for extensive stage small cell lung cancer should lead to a change in treat...
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Join GRACE at the 2017 Targeted Therapies Forum [720p]
Join us for the 2017 Targeted Therapies in Lung Cancer Patient Forum, Saturday, September 16, 2017, at the Taussig Cancer Center, Cleveland Clinic. For more info and registration, visit <a target='_blank' href='http://cancerg'>http://cancerg...</a>...
Author: cancergrace
Added: 04/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Targeted Therapies in Lung Cancer Patient Forum Breakout Met Raf Braf [360p]
Afternoon Session - Targeted Therapies in Lung Cancer Patient Forum Breakout Webcast Recording - MET/RET/BRAF, with Dr. Karen Reckamp, Dr. Vamsidhar Velcheti, and Sara Whitlock, RET patient.
Author: cancergrace
Added: 04/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Cardiac doses of radical radiotherapy impact survival in NSCLC: a real-world analysis
Radical thoracic radiotherapy is a mainstay in the treatment of non-small cell lung cancer (NSCLC); however, the effect of cardiac doses on survival is becoming increasingly important, as highlighted ...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
A new standard of care for advanced lung cancer: whats next for pembrolizumab?
The anti-PD-1 antibody therapy pembrolizumab is an exciting new agent for the treatment of non-small cell lung cancer (NSCLC). Here, Martin Reck, MD, PhD, of the Lung Clinic Grosshansdorf, Grosshansdo...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
